longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Structure Therapeutics(GPCR.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position

nasdaq·05/10/2026 20:05
US
GPCR
+2.76%
US
LABU
+11.76%
US
SBIO
+3.75%
nasdaq·05/10/2026 20:05
US
GPCR
+2.76%
US
LABU
+11.76%
US
SBIO
+3.75%

Structure Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·05/08/2026 05:14
US
GPCR
+2.76%
Earnings Watch·05/08/2026 05:14
US
GPCR
+2.76%

Structure Therapeutics appoints Matthew Lang as COO and General Counsel

TradingView·04/15/2026 18:13
US
GPCR
+2.76%
US
IBB
+2.27%
US
FBT
+2.14%
TradingView·04/15/2026 18:13
US
GPCR
+2.76%
US
IBB
+2.27%
US
FBT
+2.14%

Aberdeen Group plc Sells 322,000 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR

Market Beat·04/07/2026 15:04
US
ARKG
+5.05%
US
IXJ
+0.35%
US
BBH
+0.96%
Market Beat·04/07/2026 15:04
US
ARKG
+5.05%
US
IXJ
+0.35%
US
BBH
+0.96%

We Did The Math GXC Can Go To $124

nasdaq·04/03/2026 21:40
US
LEGN
+4.38%
US
GXC
+0.53%
US
GPCR
+2.76%
nasdaq·04/03/2026 21:40
US
LEGN
+4.38%
US
GXC
+0.53%
US
GPCR
+2.76%
© 2026 Longbridge|Disclaimer

Event Tracking

May8
Structure Therapeutics released FY2026 Q1 earnings on May 7 (EST), actual revenue USD 0 (forecast USD 11.11 M), actual EPS USD -1.0724 (forecast USD -0.31)
03:00
Feb27
Structure Therapeutics released FY2025 earnings on February 26 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.4 (forecast USD -1.3718)
04:00
Structure Therapeutics released FY2025 Q4 earnings on February 26 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD 0.5206 (forecast USD -0.369)
04:00
Feb26
Structure Therapeutics Reports Q4 Net Income and Outlines R&D Plans
21:32
Structure Therapeutics Inc. reports a fiscal year operating loss of $176.56 million
21:02
Jan14
Structure Therapeutics CEO says need to build relationships with primary care physicians
20:02

Schedules & Filings

Schedules
Filings
May7
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Net Income -75.97 M, EPS -1.0724

Feb26
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income 33 M, EPS 0.5206

Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -65.71 M, EPS -1.1234

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
6.080
+2,485.03%
+5.845
HCWB
2.430
+129.25%
+1.370
SLXN
0.5298
+96.95%
+0.261
VIDA
4.150
+81.22%
+1.860
GCL
0.7445
+72.46%
+0.313
PHGE
0.5969
+59.60%
+0.223
MTVA
2.890
+53.72%
+1.010
MWC
7.150
+51.48%
+2.430
PETZ
1.150
+41.98%
+0.340
MLGO
5.360
+39.95%
+1.530
View More